Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

Por Langerød, A, Andersen, TI, Bukholm, I, Børresen Dale, A-L
Publicado em 2000

Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP

Por Kringen, P, Eiken, HG, Pedersen, JC, Egedal, S, Berg, K, Tveit, KM, Andersen, TI
Publicado em 2000

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer

Por Andersen, TI, Skovlund, E, Bukholm, IK, Jacobsen, U, Kåresen, R, Erikstein, B, Nesland, J, Børresen-Dale, A-L
Publicado em 2000

Screening breast cancer patients for Norwegian ATM mutations

Por Laake, K, Vu, P, Andersen, TI, Erikstein, B, Kåresen, R, Lønning, PE, Skovlund, E, Børresen-Dale, A-L
Publicado em 2000